Staying PrEPared: An Update on Injectable Pre-Exposure Prophylaxis
![20210915 – Staying PrEPared – An Update on Injectable PrEP Title Slide Staying PrEPared - An Update on Injectable PrEP Title Slide](https://www.seaetc.com/wp-content/uploads/2021/09/20210915-Staying-PrEPared-An-Update-on-Injectable-PrEP-Title-Slide.png)
Facilitated by Christopher Hurt, MD
Associate Professor of Medicine, Division of Infectious Diseases
Director, North Carolina HIV Training and Education Center
Co-Leader, UNC CFAR PrEP Scientific Working Group
UNC Site PI, Ryan White HIV/AIDS Program Part D
September 15, 2021
Other Trainings
- Webinar: HIV Pre-Exposure Prophylaxis 2023
- Webinar: Implementation of Evidence-Based Interventions in HIV Prevention and Care: From Malawi to North Carolina
- Archived Session: HIV Prevention for Women in the South
- Webinar: Update on PrEP: Focus on the Medications
- Webinar: Legislation and HIV PrEP/PEP Prescribing for Pharmacists
Objectives
- Name the currently available options for pre-exposure prophylaxis (PrEP) in the United States.
- Outline key clinical trial data supporting the use of long-acting injectables for HIV prevention.
- Identify candidates for PrEP who might benefit from a long-acting, injectable option.
- Describe other long-acting forms of PrEP in the development pipeline.
Presentation
Slides & Resources
![20210915 – Staying PrEPared – An Update on Injectable PrEP Title Slide Staying PrEPared - An Update on Injectable PrEP Title Slide](https://www.seaetc.com/wp-content/uploads/2021/09/20210915-Staying-PrEPared-An-Update-on-Injectable-PrEP-Title-Slide.png)
Facilitated by Christopher Hurt, MD
Associate Professor of Medicine, Division of Infectious Diseases
Director, North Carolina HIV Training and Education Center
Co-Leader, UNC CFAR PrEP Scientific Working Group
UNC Site PI, Ryan White HIV/AIDS Program Part D
September 15, 2021
Objectives
- Name the currently available options for pre-exposure prophylaxis (PrEP) in the United States.
- Outline key clinical trial data supporting the use of long-acting injectables for HIV prevention.
- Identify candidates for PrEP who might benefit from a long-acting, injectable option.
- Describe other long-acting forms of PrEP in the development pipeline.
Presentation
Slides & Resources
Other Trainings
- Webinar: HIV Pre-Exposure Prophylaxis 2023
- Webinar: Implementation of Evidence-Based Interventions in HIV Prevention and Care: From Malawi to North Carolina
- Archived Session: HIV Prevention for Women in the South
- Webinar: Update on PrEP: Focus on the Medications
- Webinar: Legislation and HIV PrEP/PEP Prescribing for Pharmacists